Endoscopy 2025; 57(S 02): S487-S488
DOI: 10.1055/s-0045-1806260
Abstracts | ESGE Days 2025
ePosters

Characteristics and management of patients with lower gastrointestinal bleeding (LGIB): A retrospective analysis of a prospectively maintained database

Authors

  • P Gkolfakis

    1   Konstantopouleio-Patision General Hospital of Nea Ionia, Athens, Greece, Athens, Greece

  • A Panagaki

    2   Konstantopouleio-Patision General Hospital of Nea Ionia, Athens, Greece

  • G Aggelopoulos

    2   Konstantopouleio-Patision General Hospital of Nea Ionia, Athens, Greece

  • G Gerasimatos

    3   Department of Gastroenterology, Agia Olga, “Konstantopouleio”, Athens, Greece, Athens, greece, Greece

  • N Mathou

    2   Konstantopouleio-Patision General Hospital of Nea Ionia, Athens, Greece

  • G Tziatzios

    4   Department of Gastroenterology, General Hospital of Nea Ionia “Konstantopoulio-Patision”, Athens, Greece

  • A Giannakopoulos

    2   Konstantopouleio-Patision General Hospital of Nea Ionia, Athens, Greece

  • K Paraskeva

    4   Department of Gastroenterology, General Hospital of Nea Ionia “Konstantopoulio-Patision”, Athens, Greece
Further Information
Also available at
 

Aims Effective management of LGIB in a hospital setting requires a multidisciplinary approach to achieve optimal outcomes. In this study, we aim to present the characteristics and management of patients with LGIB in a tertiary hospital.

Methods We retrospectively interrogated a prospectively collected single-center database of adult patients presenting with LGIB upon admission or during their hospitalization, from December 2022 to October 2024. We assessed data including patients’ demographic characteristics, procedural and clinical outcomes that were collected through the hospital’s reporting software.

Results In total, 117 patients with LGIB were included (mean patient age 77±13 years, 50.4% men) in the analysis with mean hospitalization 7±7 days. Among the patients, 32.5% (n=38) were on antiplatelet therapy, and 16.2% (n=19) received red blood cell transfusions. Additionally, 35% (n=41) patients were on anticoagulants, with 22.2% (n=26) receiving RBC transfusions. Colonoscopy was performed in 48.7% of the cases [95%CI (39.7%-57.8%)] (n=57), but only 12% (n=14) were performed within 24 hours from admission. An endoscopic modality identified the cause of LGIB in 65% (n=76) [95%CI (56.3%-73.6%) of the cases, in the majority, 43.6% (n=51) with the performance of colonoscopy, while diverticular disease 21.4% (n=25) and malignancy/advance polyp 17.1% (n=20) were the commonest diagnoses. Endoscopic treatment was applied in 17.1% (n=20) cases; mechanical therapy with clips in 11.1%(n=13), argon plasma coagulation (APC) in 3.4% (n=4), combination of the methods in 2.6% (n=3). In-hospital mortality was 11.1% [95%CI (5.4%-16.8%)] (n=13), while re-bleeding rate during the same hospitalization was 5.1% [95%CI (1.1%-9.1%)] (n=6). The commonest cause of death was shock 6.8% (n=8) (septic, cardiac, unspecified), followed by cadiac arrest 2.5% (n=3). Out of the patients that suffered in-hospital mortality, only 1.7% (n=2) of them presented with LGIB on admission.

Conclusions This study indicates that LGIB is prevalent in older patients. Also, LGIB has significant in-hospital mortality thus only a limited number of patients necessitates an endoscopic treatment.



Publication History

Article published online:
27 March 2025

© 2025. European Society of Gastrointestinal Endoscopy. All rights reserved.

Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany